Lung Cancer

Decline in Lung Cancer Mortality Affects Decreases in Overall Cancer Deaths

By

Britt Gambino

Publish Date January 14, 2020

Reductions in lung cancer mortality are driving the steady decline in overall cancer deaths.

Lung Cancer Screening: Rates Remain Low and Disparities Run High

By

Tori Rodriquez, MA, LPC, AHC

Publish Date December 30, 2019

Despite resources, lung cancer screening with low-dose computed tomography remains underutilized.

Vaping Injuries Raise New Concerns About Medical Marijuana

By

Bryant Furlow

Publish Date November 19, 2019

Many recent vaping injuries have been linked to e-cigarette use of THC oils or other cannabis oil products, raising new concerns about patients with cancer who use the devices for medical marijuana.

USPSTF Advises Annual Low-Dose CT Lung Screening for High-Risk Individuals

Annual CT screening recommended for patients aged 50 to 80 years at high risk for lung cancer from smoking.

Quality of Life Worse for Patients With Cancer During COVID-19

Quality of life was significantly lower in patients with cancer than reference group.

Bodyweight-Based Dosing of Nivolumab Results in Wastage

A review of practices prior to a change in nivolumab dosing demonstrated that bodyweight dosing resulted in a 6.1% rate of wastage at a significant cost compared with a fixed dose of 240 mg per dose.

Racial Disparities Seen in PET/CT Imaging for Lung Cancer

Black and Hispanic patients are less likely to receive recommended imaging at time of diagnosis of NSCLC.

Lurbinectedin Approved for Metastatic Small Cell Lung Cancer

The FDA has approved lurbinectedin for the treatment of adult patients with metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy.